R&G PharmaStudies Co Ltd
SZSE:301333
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
R&G PharmaStudies Co Ltd
SZSE:301333
|
CN |
|
Kainos Laboratories Inc
TSE:4556
|
JP |
|
Delta Electronics Inc
TWSE:2308
|
TW |
|
Ligand Pharmaceuticals Inc
NASDAQ:LGND
|
US |
|
Oatly Group AB
NASDAQ:OTLY
|
SE |
|
Kenedix Office Investment Corp
TSE:8972
|
JP |
|
N
|
Netskope Inc
NASDAQ:NTSK
|
US |
|
FormPipe Software AB
STO:FPIP
|
SE |
|
Healthia Ltd
ASX:HLA
|
AU |
|
S
|
Supermax Corporation Bhd
KLSE:SUPERMX
|
MY |
|
A
|
American Airlines Group Inc
F:A1G
|
US |
|
Tetra Technologies Inc
NYSE:TTI
|
US |
|
Locality Planning Energy Holdings Ltd
ASX:LPE
|
AU |
Intrinsic Value
The intrinsic value for R&G PharmaStudies Co Ltd (301333) under the Base Case is hidden CNY. Compared with the current market price of 44.58 CNY, the stock appears hidden .
R&G PharmaStudies Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if R&G PharmaStudies Co Ltd is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for R&G PharmaStudies Co Ltd.
The intrinsic value for R&G PharmaStudies Co Ltd (301333) under the Base Case is hidden CNY.
Compared with the current market price of 44.58 CNY, the stock appears hidden.
